Research ArticleCLINICAL INVESTIGATION
18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors
Esther G.C. Troost, Johan Bussink, Aswin L. Hoffmann, Otto C. Boerman, Wim J.G. Oyen and Johannes H.A.M. Kaanders
Journal of Nuclear Medicine June 2010, 51 (6) 866-874; DOI: https://doi.org/10.2967/jnumed.109.069310
Esther G.C. Troost
Johan Bussink
Aswin L. Hoffmann
Otto C. Boerman
Wim J.G. Oyen
Johannes H.A.M. Kaanders

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 51, Issue 6
June 2010
18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors
Esther G.C. Troost, Johan Bussink, Aswin L. Hoffmann, Otto C. Boerman, Wim J.G. Oyen, Johannes H.A.M. Kaanders
Journal of Nuclear Medicine Jun 2010, 51 (6) 866-874; DOI: 10.2967/jnumed.109.069310
Jump to section
Related Articles
Cited By...
- Hybrid Imaging PET/CT with Application of 18F-Fluorothymidine in Patients with Head and Neck Carcinoma Undergoing Radiotherapy
- Parametric Method Performance for Dynamic 3'-Deoxy-3'-18F-Fluorothymidine PET/CT in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Carcinoma Patients Before and During Therapy
- Repeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma
- Imaging-Based Treatment Adaptation in Radiation Oncology
- Advances in Radiotherapy for Head and Neck Cancer
- PET Imaging in Head and Neck Cancer Patients to Monitor Treatment Response: A Future Role for EGFR-Targeted Imaging
- PET Imaging of Proliferation with Pyrimidines
- 18F-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome
- PET Imaging During Radiotherapy of Head and Neck Cancer
- Sepantronium Bromide (YM155) Enhances Response of Human B-Cell Non-Hodgkin Lymphoma to Rituximab
- Usefulness of 3'-Deoxy-3'-18F-Fluorothymidine PET for Predicting Early Response to Chemoradiotherapy in Head and Neck Cancer